Evidence map›Paper›PMID 24532586›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

A key regulatory role for Vav1 in controlling lipopolysaccharide endotoxemia via macrophage-derived IL-6.

Stefanie Zenker, Julia Panteleev-Ivlev, Stefan Wirtz, Tadamitsu Kishimoto, Maximilian J Waldner, Olga Ksionda, Victor L J Tybulewicz, Markus F Neurath, Imke Atreya

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Stefanie ZenkerMedical Clinic 1, Friedrich-Alexander University of Erlangen-Nürnberg, University Hospital of Erlangen, Germany.
Julia Panteleev-IvlevMedical Clinic 1, Friedrich-Alexander University of Erlangen-Nürnberg, University Hospital of Erlangen, Germany.
Stefan WirtzMedical Clinic 1, Friedrich-Alexander University of Erlangen-Nürnberg, University Hospital of Erlangen, Germany.
Tadamitsu KishimotoOsaka University, Suita City, Japan.
Maximilian J WaldnerMedical Clinic 1, Friedrich-Alexander University of Erlangen-Nürnberg, University Hospital of Erlangen, Germany.
Olga KsiondaMRC National Institute for Medical Research, London, United Kingdom.
Victor L J TybulewiczMRC National Institute for Medical Research, London, United Kingdom.
Markus F Neurath *Medical Clinic 1, Friedrich-Alexander University of Erlangen-Nürnberg, University Hospital of Erlangen, Germany.
Imke Atreya *Medical Clinic 1, Friedrich-Alexander University of Erlangen-Nürnberg, University Hospital of Erlangen, Germany.
Universitätsklinikum Erlangen · DEMedical Research Council · GBComprehensive Cancer Center Erlangen · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEOsaka University · JP

Funding

Medical Research Council MC_U117527252Medical Research Council U117527252
6 · The paper itself

Abstract

Macrophages are centrally involved in the pathogenesis of acute inflammatory diseases, peritonitis, endotoxemia, and septic shock. However, the molecular mechanisms controlling such macrophage activation are incompletely understood. In this article, we provide evidence that Vav1, a member of the RhoGEF family, plays a crucial role in macrophage activation and septic endotoxemia. Vav1-deficient mice demonstrated a significantly increased susceptibility for LPS endotoxemia that could be abrogated by anti-IL-6R Ab treatment. Subsequent studies showed that Vav1-deficient macrophages display augmented production of the proinflammatory cytokine IL-6. Nuclear Vav1 was identified as a key negative regulator of macrophage-derived IL-6 production. In fact, Vav1 formed a nuclear DNA-binding complex with heat shock transcription factor 1 at the HSE2 region of the IL-6 promoter to suppress IL-6 gene transcription in macrophages. These findings provide new insights into the pathogenesis of endotoxemia and suggest new avenues for therapy.

Indexed as

AnimalsBlotting, WesternCells, CulturedDNA-Binding ProteinsEndotoxemiaGene ExpressionHeat Shock Transcription FactorsInterleukin-10Interleukin-6Kaplan-Meier EstimateLipopolysaccharidesMacrophage ActivationMacrophagesMiceMice, Inbred BALB CMice, Inbred C57BLDNA-Binding ProteinsHeat Shock Transcription FactorsHsf1 protein, mouseInterleukin-10Interleukin-6LipopolysaccharidesProto-Oncogene Proteins c-vavTranscription FactorsTumor Necrosis Factor-alphaVav1 protein, mouse

Identifiers

PMID24532586
PMCPMC3951479
OpenAlexW2098274515

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.